Distribution of HIV-1 plasma RNA viral load and CD4+ T-cell counts among HIV-infected Africans evaluated for antiretroviral therapy [2]

Journal of Acquired Immune Deficiency Syndromes

Volumn 28, Issue 1, 2001, Pages 99-101

  Nkengasong, John N ^a,b   Borget, Marie Yolande ^a   Maurice, Chantal ^a   Boateng, Emmanuel ^a   Kalou, Mireille ^a   Djomand, Gaston ^a   Ekpini, Rene ^a   Eholie, Serge ^c   Bissagene, Emmanuel ^c   Coulibaly, Makan ^d   Wiktor, Stefan Z ^a,b   Roels, Thierry H ^a,b   Chorba, Terence ^a,b  

^a Project RETRO CI Abidjan   (Côte d’Ivoire)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Department of Clinical Microbiology   (Côte d’Ivoire)

^d UNAIDS   (Côte d’Ivoire)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA; ANTI HIV AGENTS; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; CONTROLLED STUDY; COTE D'IVOIRE; FEMALE; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD; BLOOD; ETHNOLOGY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; VIROLOGY;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COTE D'IVOIRE; FEMALE; HIV INFECTIONS; HIV-1; HUMAN; MALE; RNA, VIRAL; SUPPORT, U.S. GOV'T, P.H.S.; VIRAL LOAD;

EID: 0035455586     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200109010-00016     Document Type: Letter

References (8)

1. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort
2. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions
3. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy
4. The clinical effectiveness of antiretroviral multitherapy in a limited resource context: The example of the Senegalese ARV access initiative
5. Challenges for sustaining long-term care and follow-up for HIV infected persons on sophisticated antiretroviral therapy in a developing country
6. Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naïve HIV-1 infected patients
7. Late initiation of antiretroviral therapy (at CD4+ lymphocytes counts 200 cells/μl) is associated with increased risk of death
8. Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus